A major change in health coverage took effect Wednesday, July 1, and two of the country’s largest retailers are stepping in to help seniors make sense of it. For the first time, Medicare has begun covering obesity drugs through a temporary government program, and Walmart and CVS Health are rolling out new services to help older Americans understand, access, and manage the benefit.

The coverage comes through a demonstration program known as Bridge, which allows eligible Medicare beneficiaries to receive GLP-1 obesity medications for a copay of about $50 per month. That represents a dramatic shift for millions of seniors. Popular weight-loss medications made by Novo Nordisk and Eli Lilly have largely been out of reach for older Americans living on fixed incomes, and the new program significantly expands access. The initiative, administered by the Centers for Medicare & Medicaid Services (CMS), is scheduled to run through the end of 2027.

The challenge is that many seniors do not yet know the benefit exists. A survey released by the Obesity Care Advocacy Network found that 82% of older Americans were unaware Medicare was beginning to cover obesity medications. Even among those who have heard about the program, determining eligibility and understanding the enrollment process can be confusing.

That is creating an opportunity for retailers with thousands of neighborhood pharmacies.

CVS Health is expanding support through its pharmacy network and MinuteClinic locations by helping patients understand coverage, navigate insurance requirements, and manage medication side effects. The company is also introducing a $49 MinuteClinic virtual visit, allowing eligible patients to speak with a licensed clinician who can evaluate them and prescribe a GLP-1 medication when appropriate.

Walmart and Sam’s Club are taking a similar approach, offering pharmacist consultations, educational materials, and assistance understanding the new Medicare benefit in stores across the country, including many rural communities where access to specialists is often limited.

For consumers, the strategy makes sense. Pharmacies are often the easiest point of entry into the healthcare system. While physician appointments may take weeks, pharmacists are available in neighborhoods every day. By helping seniors navigate a complicated new federal benefit, Walmart and CVS strengthen customer relationships while positioning themselves at the center of what could become one of the fastest-growing prescription categories in America.

The opportunity for drug manufacturers is equally significant. GLP-1 medications produced by Novo Nordisk and Eli Lilly have already transformed the pharmaceutical industry. Opening Medicare coverage to millions of beneficiaries could dramatically expand demand, especially as obesity affects more than 40% of American adults.

The program also highlights the growing debate over healthcare costs. These medications can cost hundreds of dollars each month without insurance, making widespread Medicare coverage an expensive commitment for taxpayers. Researchers also continue studying long-term outcomes, including evidence that some patients regain weight after stopping treatment, raising questions about how long coverage should continue and who should ultimately pay for it.

Another uncertainty is what happens after 2027. The Bridge demonstration was originally intended as a temporary transition before private Medicare Part D insurers assumed responsibility for broader coverage. However, several insurers declined to participate voluntarily, citing concerns about costs and program design, prompting federal officials to extend the demonstration instead.

For seniors, however, the immediate impact is straightforward. A medication that was financially out of reach for many older Americans is now available for about $50 per month for eligible beneficiaries. That could improve access to treatment for millions of people while reducing long-term health complications associated with obesity.

For Walmart and CVS, the program represents more than another prescription to fill. It is an opportunity to become trusted healthcare advisers for millions of Medicare beneficiaries at a time when pharmacies are increasingly expanding beyond dispensing medications into providing broader healthcare services.

Whether the program ultimately becomes permanent remains uncertain. Its future will depend on costs, patient outcomes, and future policy decisions. But for now, seniors have a new benefit available, and two of America’s largest pharmacy operators are racing to help them use it.

JBizNews Desk | New York
© JBizNews.com All Rights Reserved. Reproduction or distribution without written permission is prohibited.